ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer
Clinical trial NCT02514031 · TERMINATED
Trial details
- NCT number
- NCT02514031
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-24
- Primary completion
- 2018-05-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.